tiprankstipranks
Biolidics Ltd. (SG:8YY)
:8YY
Singapore Market

Biolidics Ltd. (8YY) Income Statement

Compare
1 Followers

Biolidics Ltd. Income Statement

Last quarter (Q4 2021), Biolidics Ltd.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Biolidics Ltd.'s net income was $―. See Biolidics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 483.09K$ 3.44M$ 966.13K$ 880.13K$ 1.36M
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 1.25M$ 996.34K$ 639.74K$ 391.01K$ 503.11K
EBITDA
$ -4.58M$ -3.56M$ -4.16M$ -5.28M$ -5.53M
Operating Income
$ -3.31M$ -577.88K$ -2.34M$ -4.84M$ -1.72M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -5.98M$ -4.65M$ -4.81M$ -6.25M$ -7.21M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Biolidics Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis